• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Dec22
Qunxin Bio-B and LE2025 Enter into QX027N License and Collaboration Agreement
00:22
Dec9
Quanxin Biotech-B Receives Milestone Payment and Plans to Start Clinical Trials for Dual Antibody Drug
11:22
Dec1
Qianxin Bio-B repurchased 90,000 shares for HKD 1.9612 million
13:11
Nov25
CanSino Biologics-B Repurchased 23,200 Shares at HKD 472,700
11:57
Nov19
Quanxin Biotech-B Repurchased 97,200 Shares for HKD 1,996,200
13:59
Nov17
Quanxin Biotech-B Repurchased 34,600 Shares
13:36

Schedules & Filings

Schedules
Filings
Aug15
Earning Release(CST)

FY2025 Q2 Earning Release (HKD) Revenue 113 M, Net Income -15.51 M, EPS -0.0698

Mar28
Earning Release(CST)

FY2024 Q4 Earning Release (HKD) Revenue 60.57 M, Net Income -86.95 M, EPS -0.3914

Aug15
Earning Release(CST)

FY2024 Q2 Earning Release (HKD) Revenue 24.13 M, Net Income -92.47 M, EPS -0.4265

View More

Stock List

Top Gainers
Top Decliners
Main Board
Symbol
Price
%Chg
Change
06038
0.425
+32.81%
+0.105
08635
0.570
+28.09%
+0.125
08573
0.053
+26.19%
+0.011
03830
0.080
+25.00%
+0.016
01570
6.170
+23.40%
+1.170
02315
35.080
+22.23%
+6.380
01875
2.500
+19.05%
+0.400
00145
0.265
+17.78%
+0.040
02330
0.226
+17.71%
+0.034
00209
0.173
+16.89%
+0.025
View More